CellSeal References
Journal Articles
September 2024 | CellSeal® References | Journal Articles
Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First‑in‑Human Study with Minimum 6 Months Follow‑up
Authors: M., Siemionow, S.G., Tullius, K., Bozyk, M.H., Sikorska, A., Ziemiecka, K., Siemionow, A., Niezgoda, J., Czarnota, Wachowiak, G., Bieganski, A., Heydemann
Published: Stem Cell Reviews and Reports, 2023